Among infants of women who received the Tdap pertussis booster vaccine during pregnancy, the risk of contracting pertussis was reduced by an estimated 91 percent during the first two months of life — the critical period before they can receive their first childhood acellular pertussis (DTaP) vaccination. The findings from the Kaiser Permanente Vaccine Study Center were reported today in the journal Pediatrics.

This post comes from the RSS feed of EurekaAlert, you can find more here!

Written by admin